- Haematopoesis and basic immunology
- Diagnosing haematological malignancies
- Disease group sessions - acute leukaemia, myeloma, lymphoma
- Acute toxicities
- Stem cell transplant
- Challenging conversations in early diagnosis
- What happens when things go wrong?
Newly qualified health care professionals (HCPs), new to haematology or those wanting a refresher on basic knowledge. Also open to all nurses and HCPs working with haematology patients.
Novartis has over 30 years of heritage in oncology, spanning back to the approval of the first targeted therapy and beyond, transforming the lives of people living with cancer and life-threatening blood disorders. Novartis’ bold ambition is grounded in its industry-leading oncology and haematology pipeline of more than 45 different compounds across over 70 development programmes. Novartis is at the forefront of medicines development. Novartis is a leading commercial sponsor of clinical trials in the UK with 625 trials conducted over the last 10 years and believe it is their responsibility to continue to move at pace and deliver innovations that are laser-focused on unmet patient need and the requirements of health systems.
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The company strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, you can visit their website. You can also follow AbbVie on Twitter, YouTube.
Amgen is committed to the relentless pursuit of breakthroughs and making a sustainable contribution to healthcare. A biotechnology pioneer since 1980, Amgen serves patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives.
Amgen develops innovative medicines in cancer and long-term conditions by using advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. As one of the most forward-thinking and innovative biotech companies, Amgen’s growing portfolio of medicines tackle some of the biggest healthcare burdens facing society today.
The Amgen community in the UK and Ireland is one of Amgen’s largest outside of the company headquarters in California and is a European hub for research and development. More than 500 people at Amgen in the UK and Ireland contribute to the journey that turns molecules into medicines.
For more information, visit the Amgen website.
Sign up to our education events mailing list to be kept up to date with this and future events